MGROF:OTC-Mustgrow Biologics Corp (USD)

COMMON STOCK | Agricultural Inputs |

Last Closing

USD 0.7075

Change

0.00 (0.00)%

Market Cap

USD 0.03B

Volume

400.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-03 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap
YRAIF Yara International ASA

N/A

USD 8.31B
KPLUF K&S AG

N/A

USD 3.14B
KNKZF KWS SAAT SE & Co. KGaA

N/A

USD 2.13B
BWEL Boswell J G Co

+5.00 (+0.92%)

USD 0.50B
MBCF Itafos Inc

-0.05 (-2.82%)

USD 0.32B
VRDR Verde Resources Inc

N/A

USD 0.12B
CHYI Chykingyoung Investment Develo..

N/A

USD 0.11B
PUBC PureBase Corp

N/A

USD 0.02B
EDNSF Eden Research plc

N/A

USD 0.02B
VNPKF Verde Agritech Ltd.

-0.07 (-19.64%)

USD 0.02B

ETFs Containing MGROF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Agricultural Inputs) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -23.43% 40% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -23.43% 40% F 20% F
Trailing 12 Months  
Capital Gain 3.74% 70% C- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.74% 67% D+ 55% F
Trailing 5 Years  
Capital Gain 213.33% 91% A- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 213.33% 78% C+ 88% B+
Average Annual (5 Year Horizon)  
Capital Gain 78.46% 85% B 84% B
Dividend Return 78.46% 85% B 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 236.42% 24% F 19% F
Risk Adjusted Return 33.19% 76% C+ 73% C
Market Capitalization 0.03B 70% C- 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector